IL6 and type 2 diabetes mellitus: This study aimed to identify inflammation-associated molecular targets in T2DM and to computationally evaluate the therapeutic potential of <i>Bacillus subtilis</i>-derived metabolites targeting the key inflammatory cytokine IL6.